Literature DB >> 7807950

Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria.

K Ullrich1, J Weglage, C Oberwittler, M Pietsch, B Fünders, H van Eckhardstein, J P Colombo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7807950     DOI： 10.1007/bf00711827

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  11 in total

1.  Preliminary neuropsychological test results.

Authors:  L M de Sonneville; E Schmidt; U Michel; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography.

Authors:  K L Leenders; W H Poewe; A J Palmer; D P Brenton; R S Frackowiak
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

3.  Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials.

Authors:  I Gottlob; H Weghaupt; C Vass; E Auff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

4.  Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria.

Authors:  H C Lou; C Lykkelund; A M Gerdes; H Udesen; P Bruhn
Journal:  Acta Paediatr Scand       Date:  1987-07

5.  The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour.

Authors:  E Perret
Journal:  Neuropsychologia       Date:  1974-07       Impact factor: 3.139

6.  Dopamine depletion slows retinal transmission.

Authors:  R S Dyer; W E Howell; R C MacPhail
Journal:  Exp Neurol       Date:  1981-02       Impact factor: 5.330

7.  Dopaminergic deficiency causes delayed visual evoked potentials in rats.

Authors:  M Onofrj; I Bodis-Wollner
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

8.  L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.

Authors:  K W Lange; T W Robbins; C D Marsden; M James; A M Owen; G M Paul
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Dopaminergic deficiency and delayed visual evoked potentials in humans.

Authors:  I Bodis-Wollner; M D Yahr; L Mylin; J Thornton
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

10.  The inhibitory action of monoamines on lateral geniculate neurones.

Authors:  J W Phillis; A K Tebècis; D H York
Journal:  J Physiol       Date:  1967-06       Impact factor: 5.182
View more
  4 in total

1.  Deficits in selective and sustained attention processes in early treated children with phenylketonuria--result of impaired frontal lobe functions?

Authors:  J Weglage; M Pietsch; B Funders; H G Koch; K Ullrich
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

Review 2.  Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.

Authors:  F J van Spronsen; P G Smit; R Koch
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

3.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 4.  Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?

Authors:  F J van Spronsen; Marieke Hoeksma; Dirk-Jan Reijngoud
Journal:  J Inherit Metab Dis       Date:  2009-01-13       Impact factor: 4.982
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.